Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$366,103
+$14,605 QoQ
Shares Held
1,011
+1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2,405
of 3,140 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobsen Capital Management holds $5,455,034 across 7 Drug Manufacturers - General names. AMGN ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,543 | $1,850,720 | |
| 2 | JNJ |
Johnson & Johnson
|
4,712 | $1,196,706 | |
| 3 | ABBV |
AbbVie Inc.
|
3,660 | $921,002 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,798 | $616,543 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,011 | $366,103 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,997 | $252,300 | |
| 7 | PFE |
Pfizer Inc
|
10,451 | $251,660 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,103 | 1,011 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $351,498 | 999 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $327,310 | 1,000 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $284,739 | 1,009 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $282,839 | 1,013 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $265,440 | 852 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $206,948 | 794 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $259,701 | 806 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $249,335 | 798 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $218,642 | 769 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $220,911 | 767 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||